Meiji Consolidates Drug And Food Business To Achieve Synergy
This article was originally published in PharmAsia News
Executive Summary
Meiji Holdings released a long-term business plan aiming to increase sales by 35 percent to ¥1.5 trillion in 2020 through a business consolidation